Priv.-Doz. Dr. med. Arnim Quante – Weitere Informationen

Seit 2020

Leitung der Bereiche Gerontopsychiatrie inkl. der Gerontopsychiatrischen Institutsambulanz (GIA) sowie der Tagesklinik für Allgemeinpsychiatrie  

Seit 02/2015

Friedrich von Bodelschwingh-Klinik, Berlin Geschäftsführender Oberarzt mit Leitung der Bereiche Gerontopsychiatrie und Schizophrenie
Gastdozent und assoziierter Wissenschaftler der Charité

09/2009 – 01/2015 

Charité -  Campus Benjamin Franklin, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Berlin, Klinikdirektorin Frau Prof. Dr. Isabella Heuser
Oberarzt des Moduls "Integrative Psychiatrie" mit Leitung einer allgemein-psychiatrischen Station sowie des Konsiliardienstes
Leitung und Mitarbeit an diversen Forschungsprojekten im Bereich der affektiven Erkrankungen / Konsiliardienst / Psychopharmakologie

10/2014 

Habilitation / Venia Legendi
Thema: „Symptom- und verlaufsorientierte psychopharmakologische Interventionen bei affektiven Störungen“

08/2008
Facharzt für Psychiatrie und Psychotherapie

09/2003 – 09/2009
Charité – Campus Benjamin Franklin, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie
Wissenschaftlicher Mitarbeiter der Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie der Charité – Campus Benjamin Franklin, Leitung Frau Prof. Dr. Isabella Heuser
Ärztliche Tätigkeiten auf verschiedenen Stationen, u.a. Schwerpunktation für affektive Störungen, Gerontopsychiatrie, Akutpsychiatrie sowie allgemein-psychiatrische Station inklusive Suchtmedizin und Schwerpunkt Komorbidität
Leitung der Hochschulambulanz für affektive Erkrankungen
Mitarbeit und Leitung (inkl. Drittmitteleinwerbung) verschiedener Forschungsprojekte mit Schwerpunkt Psychopharmakologie bei affektiven Erkrankungen
Institut für Verhaltenstherapie (IVB), Berlin sowie klinikintern: Psychotherapie-Ausbildung (Verhaltenstherapie)

03/2002 – 09/2003
Vivantes Auguste-Viktoria-Klinikum, Arzt im Praktikum an der Neurologischen Klinik, Leitung Prof. Dr. Roland Schiffter und Priv.-Doz. Dr. Eva Schielke

07/2002
Promotion zum Thema „Zytokine im Nabelschnurblut zur Früherkennung einer neonatalen Infektion“, Leitung: Prof. Dr. Joachim W. Dudenhausen

Medizin
Zertifikat „Gerontopsychiatrie, -psychotherapie und -psychosomatik“ (DGPPN, DGGPP)

Betriebswirtschaft
Management psychiatrischer und psychosomatischer Kliniken, mibeg-Institut Medizin, Köln

Komplementärmedizin
Diplom in Akupunktur, Deutsche Akupunktur Gesellschaft, 2000

 

• Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik (DGPPN)

• Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)

• Leopold S, Quante A. Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review.
  Nervenarzt. 2023 Mar 15. doi: 10.1007/s00115-023-01454-y. Online ahead of print.
• Quante A. The Drawbacks of Pharmacotherapy Without Accompanying Psychotherapy. Dtsch Arztebl Int. 2023 Feb 10;120(6):96. doi: 10.3238/arztebl.m2022.0336.
• Piel C, Quante A.  Therapy Strategies for Late-life Depression: A Review. J Psychiatr Pract. 2023 Jan 1;29(1):15-30. doi: 10.1097/PRA.0000000000000678.
• Quante A. Warning of Generalizations. Dtsch Arztebl International 2021 Okt15: 693. www.aerzteblatt.de/int/article.asp
• Knorz AL, Quante A. Alzheimer's Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review. J Geriatr Psychiatry Neurol. 2021 Sep 3:8919887211044746. doi: 10.1177/08919887211044746. Online ahead of print. Free access: journals.sagepub.com/doi/10.1177/08919887211044746;
• Quante A, Schulz K, Fissler M. Psychiatric comorbidities in cancer patients: acute interventions by the psychiatric consultation liaison service. Wien Med Wochenschr. 2020 Feb 28.Online ahead pf print. 
• Quante A. Risk of Rehospitalization can be Reduced. Dtsch Arztebl Int. 2019 Oct 11;116(41):689. doi: 10.3238/arztebl.2019.0689a. 
• Quante A, Siedler J. intramuscular Aripiprazole in the Therapy of Acute Mania for More than 24 hrs.Psychiatry Investig. 2019 Aug;16(8):629-630. doi: 10.30773/pi.2019.06.10. Epub 2019 Aug 21. 
• Suehler S, Quante A: Lithium in the treatment of old age depression. What are the pros and cons? Fortschr Neurol Psychiatr. 2018 Dec;86(12):754-762. doi: 10.1055/a-0644-2578. Epub 2019 Jan 7. 
• Quante A. Behavior disorders in dementia: demands for personnel adaptation are more than justified. Nervenarzt. 2018 May;89(5):589-590.
• Quante A, Sulejmani A. Prevalence and Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia in a Geriatric Psychiatry Unit: A Retrospective Analysis. Prim Care Companion CNS Disord. 2017 Jul 27;19(4).
• Quante A. Hyponatremia Is a Common Cause.Dtsch Arztebl Int. 2017 Apr 21;114(16):289.
• Quante A. Improved suicide prevention through consultation psychiatry in general hospitals. Nervenarzt. 2017 Mar;88(3):308.
• Quante A. Cooperation between geriatrics and gerontopsychiatry is important. Nervenarzt. 2016 Oct;87(10):1111-1112.
• Mews MR, Tauch D, Erdur H, Quante A. Comparing consultation-liaison psychiatrist's and  neurologist's approaches to delirium - A retrospective analysis. Int J Psychiatry Med. 2016 Apr;51(3):284-301. doi: 10.1177/0091217416651256.
• Anderson C, Tauch D, Quante A. Diagnosis and Treatment Procedures for Patients With Anxiety Disorders by the Psychiatric Consultation Liaison Service in a General Hospital in Germany: A Retrospective Analysis. Prim Care Companion CNS Disord. 2015 Oct 8;17(5). doi: 10.4088/PCC.15m01805. eCollection 2015.
• Fißler M, Quante A. Psychiatric liaison consultations of patients without psychiatric illness in a general hospital in Germany: a retrospective analysis. Wien Med Wochenschr. 2015 Nov;165(21-22):436-44. doi: 10.1007/s10354-015-0384-3. Epub 2015 Sep 16.
• Quante A. Acute pharmacotherapy for anxiety symptoms in depression. Fortschr Neurol Psychr. 2015 Mar;83(3):142-8. doi: 10.1055/s-0034-1399243. 
• Rombold F, Lauterbach E, Felber W, Mueller-Oerlinghausen B, Ahrens B, Bronisch T, Kilb B, Lewitzka U, Richter K, Broocks A, Heuser-Gervais I, Hohagen F, Quante A. Adjunctive Lithium Treatment in the Prevention of Suicidal Behaviour in Patients with Depression and Comorbid Personality Disorders. Int J Psychiatry Clin Pract. 2014 Jul 4:1-12.
• Anderson C, Quante A. Acute Interventions and Referral of Patients With Bipolar Disorder by the Psychiatric Consultation Liaison Service in a General Hospital in Germany: A Retrospective Analysis. Prim Care Companion CNS Disord. 2014. 
• Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A, Regen F, Bajbouj M, Zimmermann-Viehoff F, Wiedemann K, Hinkelmann K. Mineralocorticoid Receptor Stimulation Improves Cognitive Function and Decreases Cortisol Secretion in Depressed Patients and Healthy Individuals. Neuropsychopharmacology. 2014 Jul 18.
• Fissler M, Quante A. A Case Series on the use of Lavendula Oil Capsules in Patients     suffering from Major Depressive Disorder and Symptoms of Psychomotor Agitation,     Insomnia and Anxiety. Complement Ther Med. 2014 Feb;22(1):63-9.    
• Anderson C, George D, Quante A. Pregabalin in acute treatment of anxious depression:     A case series. Psychiatry Res. 2014 Jan 30;215(1):246-8
• Mews MR, Rombold F, Quante A. Efficacy and safety of low-dose doxepin in depressed patients suffering from insomnia: A retrospective, naturalistic case series analysis. Prime Care Companion CNS Disord 2014; 16(1).  
• Tauch D, Winkel S, Quante A. Psychiatric Consultations and Therapy Recommendations Following a Suicide Attempt in a General Hospital and their     Associations with selected Parameters in a One Year Period. Int  J Psychiatry Clin Pract. 2014 Jun;18(2):118-24.
• Brakemeier EL, Merkl A, Wilbertz G, Quante A, Regen F, Bührsch N, van Hall F, Kischkel E, Danker-Hopfe H, Anghelescu I, Heuser I, Kathmann N, Bajbouj M. Cognitive-Behavioral Therapy as Continuation Treatment to Sustain Response After Electroconvulsive Therapy in Depression: A Randomized Controlled Trial. Biol Psychiatry. 2013 Dec 12.
• Quante A, Regen F, Schindler F, Volkmer K, Severus E, Urbanek C, Luborzewski A, Roepke S, Anghelescu I. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study. Psychiatr Danub. 2013 Sep;25(3):214-20.
• Zeugmann S, Buehrsch N, Bajbouj M, Heuser I, Anghelescu I, Quante A. Childhood maltreatment and adult proinflammatory status in patients with major depression. Psychiatr Danub. 2013 Sep;25(3):227-35.
• Mews M, Quante A. Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder – a retrospective case series and systematic review  of the literature. J Clin Psychopharmacol. 2013 Aug;33(4):512-9.
• Quante A, Zeugmann S. Tranylcypromine and bupropion combination therapy in    treatment-resistant major depression: a report of 2 cases. J Clin Psychopharmacol. 2012 Aug;32(4):572-4. 
• Bernard F, Quante A. Acoustic hallucinations and pseudo-hallucinations in acquired deafness. Antipsychotic treatment. HNO. 2011 May;59(5):519-21-
• Merkl A, Schubert F, Quante A, Luborzewski A, Brakemeier EL, Grimm S, Heuser I, Bajbouj M. Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry. 2011 Apr 15;69(8):772-9.
• Roepke S, Luborzewski A, Schindler F, Quante A, Anghelescu I, Heuser I, Bajbouj M. Stimulus Pulse-Frequency-Dependent Efficacy and Cognitive Adverse Effects of Ultrabrief-Pulse Electroconvulsive Therapy in Patients With Major Depression. J ECT. 2011 Jun;27(2):109-13.
• Quante A, Zeugmann S, Regen F, Engelhardt A, Anghelescu IG. Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany. Psychiatry Investig. 2010 Sep;7(3):155-62-
• Quante A, Luborzewski A, Brakemeier EL, Merkl A, Danker-Hopfe H, Bajbouj M. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: A randomized, double-blind pilot study. J Psychiatr Res. 2011 Feb;45(2):174-8
• Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C, Anghelescu I, Wolf J. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Hum Psychopharmacol. 2010 Mar;25(2):126-32.
• Zeugmann S, Quante A, Heuser I, Schwarzer R, Anghelescu I. Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome. J Clin Psychiatry. 2010 Aug;71(8):1007-16.
• Quante A, van Hall F, Anghelescu I. Psychopharmacological combination therapy in bipolar disorder. Fortschr Neurol Psychiatr. 2009 May;77(5):252-62.
• Anghelescu I, Klawe C, Singer P, Fehr C, Hiemke C, Quante A, Regen F, Dahmen N, Szegedi A. Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):382-9.
• Lauterbach E, Felber W, Mueller-Oerlinghausen B, Ahrens B ,Bronisch T ,Meyer T ,Kilb B ,Lewitzka U ,Hawellek B ,Quante A, Richter K, Broocks A, Hohagen F. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand. 2008 Dec;118(6):469-79.
• Jakob F, Brakemeier EL, Schommer NC, Quante A, Merkl A, Danker-Hopfe H, Anghelescu I, Heuser I, Bajbouj M.: Ultrahigh Frequency Repetitive Transcranial Magnetic Stimulation in Unipolar Depression. J Clin Psychopharmacol. 2008 Aug;28(4):474-6.
• Quante A, Jakob F, Wolf J.: Depression preceding the onset of progressive supranuclear paralysis: a case report. J Neuropsychiatry Clin Neurosci. 2008 Spring;20(2):247-8.
• Quante A, Röpke S, Merkl A, Anghelescu I, Lammers CH.: Psychopharmacologic treatment of personality disorders. Fortschr Neurol Psychiatr. 2008 Mar;76(3):139-48.
• Quante A, Zeugmann S, Bajbouj M, Anghelescu I.: Clozapine in medication- and electroconvulsive therapy-resistant, depressed inpatients: a case series. J. Clin Psychopharmacol. 2007 Dec;27(6):715-7.
• Dettling M, Opgen-Rhein C, Quante A, Anghelescu I.: Fluoxetine for treatment of anorexia nervosa. JAMA. 2006 Nov 22;296(20):2439-40.
• Quante A, Anghelescu I: Ziprasidone in the treatment of bipolar disorder. Die Psychiatrie. 2006; 34: 255-260.
• Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC.: Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry. 2006 Jan;39(1):39-40.